Jiangsu Hanbon Science and Technology Co Ltd
688755
Company Profile
Business description
Jiangsu Hanbon Science and Technology Co Ltd is engaged in Research and development, production and sales of chromatography technology. Its chromatography products as its core, mainly providing professional separation and purification equipment, consumables and technical services for the downstream of the biopharmaceutical field.
Contact
No. 1-9, Jixian Road, No. 10, Xinzhu Road
Huai'an Economic and Technological Development Zone
Economic Development Zone, Jiangsu Province
Huaian223005
CHNT: +86 51783706908
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
652
Stocks News & Analysis
stocks
Eli Lilly receives FDA approval to add another oral GLP-1 to market
Wide moat Eli Lilly receives FDA approval for obesity pill.
stocks
Our top ASX picks in every sector
These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks
Which of the 3 giant AI IPOs should you buy?
OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,779.40 | 120.30 | -1.35% |
| CAC 40 | 7,981.27 | 164.33 | 2.10% |
| DAX 40 | 23,298.89 | 618.85 | 2.73% |
| Dow JONES (US) | 46,565.74 | 224.23 | 0.48% |
| FTSE 100 | 10,364.79 | 188.34 | 1.85% |
| HKSE | 25,017.23 | 276.80 | -1.09% |
| NASDAQ | 21,840.95 | 250.32 | 1.16% |
| Nikkei 225 | 52,537.15 | 1,202.53 | -2.24% |
| NZX 50 Index | 12,902.15 | 76.28 | 0.59% |
| S&P 500 | 6,575.32 | 46.80 | 0.72% |
| S&P/ASX 200 | 8,583.60 | 101.40 | -1.17% |
| SSE Composite Index | 3,927.60 | 20.95 | -0.53% |